Home › Stocks › ESLAW

ESLAW — ESTRELLA IMMUNOPHARMA INC

Reported value held$16.43K
Funds holding (latest)4
SectorHealth Care
Funds holding (Q2 2026)2
Institutional value$16.36K · 117.50K sh
New / Add / Cut / Exit0 / 0 / 0 / 0
Top-5 / Top-10 concentration100.0% / 100.0%
Institutional holdings change Accumulating +0.0% (+0 sh)
Institutional value change Up +95.4%

As of Q2 2026, 2 SEC-registered investment managers reported holding ESLAW (ESTRELLA IMMUNOPHARMA INC) in their latest 13F filings, with a combined reported value of $16.36K across 117.50K shares. That is +0.0% by share count (+0 shares) versus the previous quarter, while reported value moved +95.4%. Ownership is concentrated: the five largest holders account for 100.0% of reported value and the top ten for 100.0%.

ESLAW is classified in the Health Care sector.

All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.

FundQuarterSharesValuePortfolio WeightChange
D. E. Shaw & Co history Q2 2026 87.50K $12.46K 0.00% Hold
Citigroup Inc history Q2 2026 30.00K $3.90K 0.00% Hold
UBS Group AG history Q3 2025 1.28K $67 0.00% Reduce
Bank of America Corp history Q2 2024 80 $3 0.00% New

New Positions (Q2 2026)

No fund opened a new position this quarter.

Fully Exited (vs previous quarter)

No tracked fund fully exited this quarter.

Fund Position History — shares by quarter (top 4 funds)

FundQ4 2023Q1 2024Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025Q3 2025Q4 2025Q1 2026Q2 2026
D. E. Shaw & Co 87.50K 87.50K 87.50K 87.50K 87.50K 87.50K 87.50K 87.50K 87.50K 87.50K 87.50K
Citigroup Inc 30.00K 30.00K 30.00K 30.00K 30.00K 30.00K 30.00K 30.00K 30.00K 30.00K 30.00K
UBS Group AG — — 5.09K — — 4.45K 1.33K 1.28K — — —
Bank of America Corp — — 80 — — — — — — — —

Download holders (CSV)